2024

1. Analysis of Diagnostic Delay and its Impact on Lung Cancer Survival: Results From the Spanish Thoracic Tumor Registry

   Archivos de Bronconeumologia, Vol. 60, pp. S38-S45

2. BRAF mutational status is associated with survival outcomes in locally advanced resectable and metastatic NSCLC

   Lung Cancer, Vol. 194

3. Capmatinib plus nazartinib in patients with EGFR-mutated non–small cell lung cancer

   European Journal of Cancer, Vol. 208

4. Describing differences among populations of thoracic tumors patients under and over 80 years: Data analysis from the SLCG thoracic tumor registry

   Lung Cancer, Vol. 190

5. Description of clinical and genetic features of 122 patients included in the Spanish Pompe registry

   Neuromuscular Disorders, Vol. 34, pp. 1-8

6. Difficulties on the access to innovative targeted therapies for lung cancer in Spain

   Clinical and Translational Oncology, Vol. 26, Núm. 3, pp. 597-612

7. Diffuse alveolar hemorrhage in patients with systemic lupus erythematosus: data from the Spanish society of rheumathology Lupus Register (RELESSER)

   Rheumatology International, Vol. 44, Núm. 11, pp. 2445-2455

8. Family history of cancer and lung cancer: Utility of big data and artificial intelligence for exploring the role of genetic risk

   Lung Cancer, Vol. 195

9. Genetic Characterization of Kidney Failure of Unknown Etiology in Spain: Findings From the GENSEN Study

   American Journal of Kidney Diseases

10. Improving the Access of Highly Sensitized Patients to Kidney Transplantation From Deceased Donors: The Spanish PATHI Program With Allocation Based on the Virtual Crossmatch

    Transplantation, Vol. 108, Núm. 3, pp. 787-801

11. PCSK9 inhibitors on the management of primary and secondary cardiovascular prevention

    Lipids in Health and Disease , Vol. 23, Núm. 1

12. Perioperative chemotherapy and nivolumab in non-small-cell lung cancer (NADIM): 5-year clinical outcomes from a multicentre, single-arm, phase 2 trial

    The Lancet Oncology, Vol. 25, Núm. 11, pp. 1453-1464

13. Prediction of bronchopulmonary dysplasia in very preterm infants: competitive risk model nomogram

    Frontiers in Pediatrics, Vol. 12

14. Recommendations Not to do in rehabilitation and physical medicine: a compilation from different fields of intervention

    Rehabilitacion, Vol. 58, Núm. 4

15. Role of TBX20 Truncating Variants in Dilated Cardiomyopathy and Left Ventricular Noncompaction

    Circulation: Genomic and Precision Medicine, Vol. 17, Núm. 2, pp. E004404

16. SEOM-GEICO Clinical Guidelines on cervical cancer (2023)

    Clinical and Translational Oncology, Vol. 26, Núm. 11, pp. 2771-2782

17. SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort

    Lupus Science and Medicine, Vol. 11, Núm. 1

18. Spanish cardiac catheterization and coronary intervention registry. 33rd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2023)

    Revista Espanola de Cardiologia, Vol. 77, Núm. 11, pp. 936-946

19. The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy

    Clinical and Translational Oncology, Vol. 26, Núm. 7, pp. 1779-1789

20. Use of Triple Therapy in Asthma: The GEMAFORUM V Task Force

    Journal of investigational allergology & clinical immunology, Vol. 34, Núm. 4, pp. 257-260